1胡春,丁立成,邢谷盈,等4\|(2\|呋喃基)\|2\|硫代\|1,2,3,4\|四氢嘧啶\|5\|羧酸酯类化合物的合成及其钙拮抗活性\[J\]中国药物化学杂志,2001,11(5):255\|258
2Nair AC,Jayatilleke P,Wang XComputational studies on tetrahydropyrimidine\|2\|one HIV\|1 protease inhibitors:improving three\|dimensional quantitative structure\|activity relationship comparative molecular field analysis models by inclusion of calculated inhibitor\| and receptor\|based propertiesJ Med Chem,2002,45(4):973\|983
3Peters T,Lindenmaier H,Haefeli WEInteraction of the mitotic kinesin Eg5 inhibitor monastrol with P\|glycoproteinArch Pharmacol,2006,372(4):291\|299
4Russowsky D,Canto RF,Sanches SASynthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines:Monastrol,oxo\|monastrol and oxygenated analoguesBioorg Chem,2006,34(4):173\|82
5Zhang Z,Pan H,Hu CSynthesis,characterization and in vitro antitumour properties of complexes of bis(alkoxycarbonylmethyl)tin dibromides with bidentate nitrogen ligandsAppl Organomet Chem,1991,5(3):183\|190
6Russowsky D,Benvenutti EV,Roxo GSMulticomponent synthesis of 3,4\|dihydropyrimidin\|2\|(1H)\|ones with a Cu/silica xerogel composite catalystLett Org Chem,2007,4(1):39\|42
7彭祥鄂恶性肿瘤的实验化学治疗方法见：徐叔云,卞如廉,陈修药理实验方法学,北京:人民卫生出版社,1982:1115\|1146